Agger Mette Kirstine 4
4 · Lexeo Therapeutics, Inc. · Filed Feb 6, 2024
Insider Transaction Report
Form 4
Agger Mette Kirstine
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-02+36,000→ 36,000 totalExercise: $17.00Exp: 2034-02-01→ Common Stock (36,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option shall vest and become exercisable on November 2, 2024, and 1/48th of the shares underlying the option shall vest in equal monthly installments thereafter, subject to the Reporting Person's continuous service.